| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Mar 4, 2025 | AbbVie Inc. | EVP, R&D and CSO | Sell | 20.0 | -4,678 | -9.96% | ✗ | $959.1K |
| Feb 28, 2024 | Mar 1, 2024 | AbbVie Inc. | SVP, CMO, GLOBAL THERAPEUTICS | Sell | 20.0 | -4,914 | -17.44% | ✗ | $879.6K |